Loading clinical trials...
Loading clinical trials...
The main purpose of this study is to compare empasiprubart and IVIg for treating people with CIDP. This study consists of a Part A where participants will either receive empasiprubart and a placebo re...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
argenx
NCT06290141 · Chronic Inflammatory Demyelinating Polyneuropathy
NCT06858579 · Chronic Inflammatory Demyelinating Polyneuropathy
NCT06752356 · Chronic Inflammatory Demyelinating Polyneuropathy
NCT07264426 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP, and more
NCT06747351 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Colorado Springs Neurological Associates
Colorado Springs, Colorado
MedStar Washington Hospital Center
Washington D.C., District of Columbia
Homestead Associates in Research Inc
Homestead, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions